Dr. Mandelblatt is a geriatrician with health services and epidemiology training. She is currently Director of Cancer Control at Lombardi Cancer Center. Dr. Mandelblatt has a long history of continuous peer-reviewed funding almost $31 million and centered on translational research for individuals 65 years and older (hereinafter referred to as """"""""elderly"""""""" or """"""""older""""""""). Dr. Mandelblatt's focus on understanding and eliminating age and race disparities in cancer care miletus national priorities. For instance, the US Department of Health and Human Services (DHHS) has recently renewed its """"""""war on cancer"""""""" by declaring the elimination of age (and race) disparities as a key priority. The National Cancer Institute Year 2010 goals echo this priority. The importance of these national cancer control objectives is cast on the backdrop of the changing demographic profile of the US: by the year 2030, one in five will be elderly and 40 percent will be from minority groups. Despite this """"""""demographic imperative"""""""" and rising cancer rates with advancing age, there is a shortage of researchers trained to address the needs of diverse older populations. Dr. Mandelblatt is one a small cadre of scientists in the US with this expertise. One important cancer care gap, recently identified by the Institute of Medicine, is under use of chemotherapy. However, we know little about treatment decision making in regional breast cancer, where chemotherapy can have substantial benefits. Moreover, there is a paucity of data on quality of life and clinical outcomes of therapy in older women. Chemotherapy decision making is particularly complex for older women owing to limited age-related data on cancer biology, potential treatment toxicity, interactions of treatment and comorbidity, limitations in physical, social, and economic resources, and possible biases in care delivery. The research and mentoring proposed in this application will address these issues. The specific objectives proposed for this award are threefold: (1) To conduct theory-based research on patient preferences and clinical characteristics affecting decisions about use of systemic non-hormonal chemotherapy in older women with regional breast cancer, (2) To develop a research database infrastructure to conduct new studies about potential race and age-related biases in care, and (3) To develop a training infrastructure to develop young investigators in population sciences, behavioral research, and cancer control for older individuals. With this award, Dr. Mandelblatt will be able to continue her commitment to gero-oncology, have sufficient protected time to train new investigators in this nascent field, and address new research innovations to advance the science of cancer control at the intersection of aging.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Scientist Award (K05)
Project #
5K05CA096940-02
Application #
6642715
Study Section
Subcommittee G - Education (NCI)
Program Officer
Lohrey, Nancy
Project Start
2002-08-16
Project End
2007-06-30
Budget Start
2003-08-01
Budget End
2004-06-30
Support Year
2
Fiscal Year
2003
Total Cost
$138,622
Indirect Cost
Name
Georgetown University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Huei-Yu Wang, Judy; Ma, Grace X; Liang, Wenchi et al. (2018) Physician Intervention and Chinese Americans' Colorectal Cancer Screening. Am J Health Behav 42:13-26
Mandelblatt, Jeanne S; Cai, Ling; Luta, George et al. (2017) Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance). Breast Cancer Res Treat 164:107-117
Kimmick, Gretchen G; Major, Brittny; Clapp, Jonathan et al. (2017) Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503). Breast Cancer Res Treat 163:391-398
Bluethmann, Shirley M; Alfano, Catherine M; Clapp, Jonathan D et al. (2017) Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance). Breast Cancer Res Treat 165:677-686
Dur√°-Ferrandis, Estrella; Mandelblatt, Jeanne S; Clapp, Jonathan et al. (2017) Personality, coping, and social support as predictors of long-term quality-of-life trajectories in older breast cancer survivors: CALGB protocol 369901 (Alliance). Psychooncology 26:1914-1921
Chang, Yaojen; Near, Aimee M; Butler, Karin M et al. (2016) Economic Evaluation Alongside a Clinical Trial of Telephone Versus In-Person Genetic Counseling for BRCA1/2 Mutations in Geographically Underserved Areas. J Oncol Pract 12:59, e1-13
Mandelblatt, Jeanne S; Clapp, Jonathan D; Luta, Gheorghe et al. (2016) Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance). Cancer 122:3555-3563
Neugut, Alfred I; Hillyer, Grace Clarke; Kushi, Lawrence H et al. (2016) A prospective cohort study of early discontinuation of adjuvant chemotherapy in women with breast cancer: the breast cancer quality of care study (BQUAL). Breast Cancer Res Treat 158:127-138
Greenlee, Heather; Neugut, Alfred I; Falci, Laura et al. (2016) Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study. JAMA Oncol 2:1170-6
van Ravesteyn, Nicolien T; van Lier, Lisanne; Schechter, Clyde B et al. (2015) Transition from film to digital mammography: impact for breast cancer screening through the national breast and cervical cancer early detection program. Am J Prev Med 48:535-42

Showing the most recent 10 out of 85 publications